These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 25693875

  • 1. [Lymphoma of the ocular adnexa].
    Kakkassery V, Stübiger N, Adamietz IA, Tischoff I, Baraniskin A, Wunderlich IM.
    Ophthalmologe; 2015 Mar; 112(3):210-6. PubMed ID: 25693875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
    Graue GF, Finger PT, Maher E, Della Rocca D, Della Rocca R, Lelli GJ, Milman T.
    Eur J Ophthalmol; 2013 Mar; 23(3):344-55. PubMed ID: 23397158
    [Abstract] [Full Text] [Related]

  • 4. [Lymphoma of the ocular adnexa].
    Rodríguez JN, Cañavate M, Amián A, Muñiz R, Prados D.
    Rev Clin Esp; 1994 Oct; 194(10):913-5. PubMed ID: 7800873
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lymphoproliferative Tumors of the Ocular Adnexa.
    Verdijk RM.
    Asia Pac J Ophthalmol (Phila); 2017 Oct; 6(2):132-142. PubMed ID: 28399341
    [Abstract] [Full Text] [Related]

  • 7. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M, Lukenda A, Bollmann M, Kalauz M, Petrovecki M, Bollmann R.
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification.
    Kwon M, Lee JS, Lee C, Yoon DH, Sa HS.
    Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417
    [Abstract] [Full Text] [Related]

  • 9. [Lymphoma of Ocular and Periocular Tissues - Clinicopathological Correlations].
    Schmack I, Grossniklaus HE, Hartmann S.
    Klin Monbl Augenheilkd; 2016 Jul; 233(7):824-46. PubMed ID: 27468099
    [Abstract] [Full Text] [Related]

  • 10. Follicular lymphoma of the ocular adnexal region: a nation-based study.
    Rasmussen PK, Ralfkiaer E, Prause JU, Sjö LD, Specht L, Rossing HH, Siersma VD, Heegaard S.
    Acta Ophthalmol; 2015 Mar; 93(2):184-91. PubMed ID: 25125069
    [Abstract] [Full Text] [Related]

  • 11. Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa.
    Shome D, Esmaeli B.
    Curr Opin Ophthalmol; 2008 Sep; 19(5):414-21. PubMed ID: 18772675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ocular adnexal lymphoid tumors.
    Lauer SA.
    Curr Opin Ophthalmol; 2000 Oct; 11(5):361-6. PubMed ID: 11148704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lymphoma involvement of the eyelid and eye.
    Enwereji N, Falcone M, Ferenczi K.
    Clin Dermatol; 2024 Oct; 42(4):373-380. PubMed ID: 38281690
    [Abstract] [Full Text] [Related]

  • 16. [Malignant epibulbar tumours: new strategies in diagnostics and therapy].
    Westekemper H, Schallenberg M, Tomaszewski A, Nückel H, Sauerwein W, Meller D, Steuhl K.
    Klin Monbl Augenheilkd; 2011 Sep; 228(9):780-92. PubMed ID: 21487989
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?
    Restrepo A, Raez LE, Byrne GE, Johnson T, Ossi P, Benedetto P, Hamilton K, Whitcomb CC, Cassileth PA.
    Crit Rev Oncog; 1998 Sep; 9(3-4):269-73. PubMed ID: 10201631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.